Telegram Group & Telegram Channel
竹新社
知情人士指,中国交通、海关、出入境等部门正研究调整防疫政策的方案,准备未来付中央讨论。 中国卫健官员们认为冬奥闭环的运作很成功,正考虑作为样板在更多城市举办赛会时推广;也正研究豁免完整接种的国际旅客的隔离要求、为国际学生提供特别入境安排等提议。 另外,卫健官员正将香港第五波疫情视为一场压力测试,期望从中获得不动用硬封锁对抗感染爆发的经验,以及了解不同治疗手段的效力。 知情人士说,上月辉瑞的特效药Paxlovid获批紧急使用,是走向放松防疫管控的重要一步;若该药正式获批上市,将成为治疗新型肺炎突破感染的重要…
国家卫健委疾控专家委员、深圳市三院院长卢洪洲受访说,香港和南美洲研究显示以mRNA疫苗作为加强针更好刺激T细胞免疫,免疫效果和持续时间比接种3针灭活疫苗的更理想。他形容,全球而言核酸疫苗是最好的疫苗。
他认为,只有广泛在内地接种有效保护的疫苗,尤其是老年人、有基础疾病、免疫缺陷等人群打针后,内地才会对外开放,从根本解决疫情防控要靠科技。今后的发展是吸入式疫苗与肌肉注射式疫苗同等重要,理想的做法是吸入1剂疫苗并注射1剂疫苗,以防止感染、传染性、重症化。
深圳三院给24名患者使用Paxlovid,用药5天后Ct值上升至35左右,符合出院标准;至于对照统计结果即将补充。
香港电台第一财经



group-telegram.com/tnews365/21922
Create:
Last Update:

国家卫健委疾控专家委员、深圳市三院院长卢洪洲受访说,香港和南美洲研究显示以mRNA疫苗作为加强针更好刺激T细胞免疫,免疫效果和持续时间比接种3针灭活疫苗的更理想。他形容,全球而言核酸疫苗是最好的疫苗。
他认为,只有广泛在内地接种有效保护的疫苗,尤其是老年人、有基础疾病、免疫缺陷等人群打针后,内地才会对外开放,从根本解决疫情防控要靠科技。今后的发展是吸入式疫苗与肌肉注射式疫苗同等重要,理想的做法是吸入1剂疫苗并注射1剂疫苗,以防止感染、传染性、重症化。
深圳三院给24名患者使用Paxlovid,用药5天后Ct值上升至35左右,符合出院标准;至于对照统计结果即将补充。
香港电台第一财经

BY 竹新社




Share with your friend now:
group-telegram.com/tnews365/21922

View MORE
Open in Telegram


Telegram | DID YOU KNOW?

Date: |

The War on Fakes channel has repeatedly attempted to push conspiracies that footage from Ukraine is somehow being falsified. One post on the channel from February 24 claimed without evidence that a widely viewed photo of a Ukrainian woman injured in an airstrike in the city of Chuhuiv was doctored and that the woman was seen in a different photo days later without injuries. The post, which has over 600,000 views, also baselessly claimed that the woman's blood was actually makeup or grape juice. The fake Zelenskiy account reached 20,000 followers on Telegram before it was shut down, a remedial action that experts say is all too rare. Andrey, a Russian entrepreneur living in Brazil who, fearing retaliation, asked that NPR not use his last name, said Telegram has become one of the few places Russians can access independent news about the war. READ MORE "And that set off kind of a battle royale for control of the platform that Durov eventually lost," said Nathalie Maréchal of the Washington advocacy group Ranking Digital Rights.
from jp


Telegram 竹新社
FROM American